Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic review.

作者信息

Sachdeva Muskaan, Mufti Asfandyar, Kim Patrick, Maliyar Khalad, Sibbald Cathryn

机构信息

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Am Acad Dermatol. 2021 Oct;85(4):1011-1013. doi: 10.1016/j.jaad.2020.12.080. Epub 2021 Jan 8.

DOI:10.1016/j.jaad.2020.12.080

PMID:33422622

Abstract

摘要

相似文献

Biologic treatment in pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis: A systematic review.

J Am Acad Dermatol. 2021 Oct;85(4):1011-1013. doi: 10.1016/j.jaad.2020.12.080. Epub 2021 Jan 8.

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.

Ann Allergy Asthma Immunol. 2005 Apr;94(4):419-36; quiz 436-8, 456. doi: 10.1016/S1081-1206(10)61112-X.

Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.

Pediatrics. 2009 Feb;123(2):e297-304. doi: 10.1542/peds.2008-1923. Epub 2009 Jan 19.

Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.

Drug Saf. 2005;28(10):917-24. doi: 10.2165/00002018-200528100-00008.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Drug Saf. 2019 Jan;42(1):55-66. doi: 10.1007/s40264-018-0711-x.

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.

Arch Dermatol. 2002 Aug;138(8):1019-24. doi: 10.1001/archderm.138.8.1019.

Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.

Ophthalmology. 1995 Nov;102(11):1669-76. doi: 10.1016/s0161-6420(95)30811-1.

A Systematic Review of Efficacy and Safety of Monotherapy and Combination Therapy With Biologic for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

J Cutan Med Surg. 2021 Nov-Dec;25(6):598-615. doi: 10.1177/1203475421993779. Epub 2021 Feb 25.

Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.

Int J Clin Pract. 2021 Aug;75(8):e14273. doi: 10.1111/ijcp.14273. Epub 2021 May 17.

Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.

Indian J Dermatol Venereol Leprol. 2016 Nov-Dec;82(6):603-625. doi: 10.4103/0378-6323.191134.

引用本文的文献

Drug hypersensitivity reactions in children in clinical practice: A WAO Statement.

World Allergy Organ J. 2025 Aug 29;18(9):101087. doi: 10.1016/j.waojou.2025.101087. eCollection 2025 Sep.

Reactive infectious mucocutaneous eruption - repeat etanercept after intravenous immunoglobulin: A case report.

SAGE Open Med Case Rep. 2022 Aug 17;10:2050313X221117887. doi: 10.1177/2050313X221117887. eCollection 2022.

Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Paediatr Drugs. 2022 Jul;24(4):307-319. doi: 10.1007/s40272-022-00515-0. Epub 2022 Jun 9.

Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验